{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:06:07Z","timestamp":1777554367310,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2022SCUH0008"],"award-info":[{"award-number":["2022SCUH0008"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["23ZDYF1664"],"award-info":[{"award-number":["23ZDYF1664"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023YFS0158"],"award-info":[{"award-number":["2023YFS0158"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271325"],"award-info":[{"award-number":["32271325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902997"],"award-info":[{"award-number":["81902997"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrc.2026.153389","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:05:20Z","timestamp":1770077120000},"page":"153389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cetylpyridinium chloride inhibits the polarization of tumor-associated macrophages and the proliferation of triple-negative breast cancer cells"],"prefix":"10.1016","volume":"805","author":[{"given":"Gaoyue","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baihui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kefeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6004-3086","authenticated-orcid":false,"given":"Huihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153389_bib1","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153389_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.semcancer.2020.06.005","article-title":"Pathology of triple negative breast cancer","volume":"72","author":"Borri","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.153389_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbrc.2026.153389_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153389_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.25122\/jml-2021-0108","article-title":"Triple-negative breast cancer: current treatment strategies and factors of negative prognosis","volume":"15","author":"Baranova","year":"2022","journal-title":"J. Med. Life."},{"key":"10.1016\/j.bbrc.2026.153389_bib6","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153389_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115545","article-title":"Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies","volume":"212","author":"Karim","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153389_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.32604\/or.2023.028525","article-title":"Targeting triple-negative breast cancer: a clinical perspective","volume":"31","author":"Popovic","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbrc.2026.153389_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150464","article-title":"Innovative approach against cancer: Thymoquinone-loaded PHEMA-based magnetic nanoparticles and their effects on MCF-7 breast cancer","volume":"734","author":"Y\u0131ld\u0131r\u0131m","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.153019","article-title":"Current advancements in tubulin targeting agents for breast cancer: design strategies, structure-activity relationships, and pharmacological insights","volume":"793","author":"Uppal","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib11","article-title":"Comparative efficacy and safety of antibody-drug conjugates versus standard chemotherapy in metastatic breast cancer: a comprehensive systematic review and meta-analysis","volume":"17","author":"Teama","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.bbrc.2026.153389_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12032-024-02456-9","article-title":"The treatment landscape of triple-negative breast cancer","volume":"41","author":"Hu","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2026.153389_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ccell.2025.01.007","article-title":"Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.153389_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032969","article-title":"Triple-negative breast cancer and predictive markers of response to neoadjuvant chemotherapy: a systematic review","volume":"24","author":"van den Ende","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153389_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1476-4598-13-174","article-title":"Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling","volume":"13","author":"Bernemann","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153389_bib16","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12967-025-07370-w","article-title":"Recent progress in immune evasion mechanisms of triple-negative breast cancer","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.153389_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): non-genetic tumor heterogeneity and immune microenvironment: emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2026.153389_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153389_bib19","article-title":"TPI1 promotes tumor progression and M2 macrophage polarization: integrated pan-cancer and lung adenocarcinoma insights","volume":"797","author":"Liu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151098","article-title":"The role of the tumor microenvironment in tumor cell intravasation and dissemination","volume":"99","author":"Borriello","year":"2020","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153389_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S316700","article-title":"The characteristics of tumor microenvironment in triple negative breast cancer","volume":"14","author":"Fan","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbrc.2026.153389_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","article-title":"Metabolic regulation of macrophage polarization in cancer","volume":"5","author":"Mehla","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbrc.2026.153389_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","article-title":"Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/\u03b2-catenin signaling","volume":"20","author":"Chen","year":"2022","journal-title":"Cell Commun. Signal. : CCS"},{"key":"10.1016\/j.bbrc.2026.153389_bib24","first-page":"213","article-title":"Crosstalk between macrophages and breast cancer cells: networking within tumors, results Probl","volume":"74","author":"Melwani","year":"2024","journal-title":"Cell Differ."},{"key":"10.1016\/j.bbrc.2026.153389_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41419-024-07020-x","article-title":"LncRNA HAGLROS promotes breast cancer evolution through miR-135b-3p\/COL10A1 axis and exosome-mediated macrophage M2 polarization","volume":"15","author":"Meng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153389_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","article-title":"Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion","volume":"40","author":"Fang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153389_bib27","article-title":"Breast cancer-derived exosomal miR-92a-3p stimulates malignant progression by driving TLR4\/NF-\u03baB-mediated macrophage M2 polarization","volume":"795","author":"Ding","year":"2026","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib28","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41467-022-30568-1","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2017.11.043","article-title":"Blocking interleukin (IL)4- and IL13-Mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer","volume":"100","author":"Rahal","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbrc.2026.153389_bib30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41419-023-06383-x","article-title":"TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153389_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2018.03.224","article-title":"Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages","volume":"503","author":"Yang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26072001","article-title":"Recent development of active ingredients in mouthwashes and toothpastes for periodontal diseases","volume":"26","author":"Rajendiran","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153389_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijbiomac.2021.12.122","article-title":"Systematic comparison of eight methods for preparation of high purity sulfated fucans extracted from the brown alga Pelvetia canaliculata","volume":"201","author":"Nikoli\u0107 Chenais","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153389_bib34","doi-asserted-by":"crossref","DOI":"10.1289\/EHP1404","article-title":"In vitro evaluation of mitochondrial function and estrogen signaling in cell lines exposed to the antiseptic cetylpyridinium chloride","volume":"125","author":"Datta","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbrc.2026.153389_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310391","article-title":"Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis","volume":"19","author":"Cai","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153389_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110598","article-title":"Cetylpyridinium chloride triggers paraptosis to suppress pancreatic tumor growth via the ERN1-MAP3K5-p38 pathway","volume":"27","author":"Tang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2026.153389_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mito.2019.09.009","article-title":"Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer","volume":"50","author":"Allen","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbrc.2026.153389_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.108962","article-title":"Benzalkonium chloride and cetylpyridinium chloride induce apoptosis in human lung epithelial cells and alter surface activity of pulmonary surfactant monolayers","volume":"317","author":"Kanno","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2026.153389_bib39","article-title":"Reprograming of tumor-associated macrophages in breast tumor-bearing mice under chemotherapy by targeting Heme Oxygenase-1","volume":"10","author":"Kim","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.bbrc.2026.153389_bib40","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153389_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbrc.2026.153389_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153389_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1681\/ASN.2019060582","article-title":"Prolyl hydroxylase domain inhibitor protects against metabolic disorders and associated kidney disease in Obese type 2 diabetic mice","volume":"31","author":"Sugahara","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2026.153389_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153389_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2026.153389_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11033-025-11231-6","article-title":"Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights","volume":"53","author":"Sharma","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2026.153389_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7150\/ijbs.86085","article-title":"VEGFA\/NRP-1\/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153389_bib48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153389_bib49","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20141555","article-title":"FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis","volume":"212","author":"Qian","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.153389_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12951-024-02694-z","article-title":"Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer","volume":"22","author":"Xu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbrc.2026.153389_bib51","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00262-022-03343-w","article-title":"CXCL9 influences the tumor immune microenvironment by stimulating JAK\/STAT pathway in triple-negative breast cancer","volume":"72","author":"Wu","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbrc.2026.153389_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0337175","article-title":"Infiltration of CXCL9+ macrophages confers a favorable prognosis in breast cancer: insights from an integrated single-cell RNA and bulk RNA sequencing study","volume":"20","author":"Liang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153389_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12935-025-03942-4","article-title":"FPR3 orchestrates macrophage polarization in breast cancer: multi-omics dissection of prognostic relevance and therapeutic targeting","volume":"25","author":"Chen","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.153389_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcdb.2019.05.022","article-title":"Mitochondria as playmakers of apoptosis, autophagy and senescence","volume":"98","author":"Abate","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.153389_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115605","article-title":"Aminooxyacetic acid hemihydrochloride leads to decreased intracellular ATP levels and altered cell cycle of prostate cancer cells by suppressing energy metabolism","volume":"167","author":"Teng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153389_bib56","article-title":"CDK4\/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216635","article-title":"A novel antagonist of the CCL5\/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation","volume":"583","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153389_bib58","article-title":"Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation","volume":"8","author":"Wu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153389_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131903","article-title":"Structural clarification of mannoglucan GSBP-2 from Ganoderma sinense and its effects on triple-negative breast cancer migration and invasion","volume":"269","author":"Xie","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153389_bib60","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153389_bib61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","article-title":"The inflammatory chemokines CCL2 and CCL5 in breast cancer","volume":"267","author":"Soria","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153389_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005869","article-title":"CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer","volume":"16","author":"Chen","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2026.153389_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","article-title":"PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153389_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.bbrc.2026.153389_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153389_bib66","doi-asserted-by":"crossref","first-page":"981","DOI":"10.20892\/j.issn.2095-3941.2023.0294","article-title":"Hot issues in triple-negative breast cancer","volume":"20","author":"Hao","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbrc.2026.153389_bib67","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.clbc.2025.05.022","article-title":"Adjuvant chemotherapy in early triple-negative breast cancer (T1a-c N0M0): a systematic review and meta-analysis","volume":"25","author":"Moraes","year":"2025","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.bbrc.2026.153389_bib68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.33830","article-title":"Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): results from a multicenter, randomized controlled, open-label phase II trial","volume":"150","author":"Zhang","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.153389_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/tbcr-23-4","article-title":"Prospect of neoadjuvant\/adjuvant immunotherapy in early-stage triple-negative breast cancer","volume":"4","author":"Hao","year":"2023","journal-title":"Transl. Breast Cancer Res. : J. Focus. Transl. Res. Breast Cancer."},{"key":"10.1016\/j.bbrc.2026.153389_bib70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clbc.2024.03.001","article-title":"The role of immunotherapy in triple-negative breast cancer (TNBC)","volume":"24","author":"Michaels","year":"2024","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.bbrc.2026.153389_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00576-20","article-title":"Cetylpyridinium chloride: mechanism of action, antimicrobial efficacy in biofilms, and potential risks of resistance","volume":"64","author":"Mao","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2026.153389_bib72","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15080","article-title":"Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study","volume":"11","author":"Bezinelli","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrc.2026.153389_bib73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0003-9861(82)90442-8","article-title":"Anisotropic action of cetyl pyridinium chloride on rat heart mitochondria","volume":"213","author":"Ch\u00e1vez","year":"1982","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2026.153389_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104239","article-title":"Maternal exposure to cetylpyridinium chloride impairs oogenesis by causing mitochondria disorder in neonates","volume":"102","author":"Liu","year":"2023","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153389_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115913","article-title":"Cetylpyridinium chloride (CPC) reduces zebrafish mortality from influenza infection: super-resolution microscopy reveals CPC interference with multiple protein interactions with phosphatidylinositol 4,5-bisphosphate in immune function","volume":"440","author":"Raut","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153389_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113980","article-title":"Pharmaceutical agent cetylpyridinium chloride inhibits immune mast cell function by interfering with calcium mobilization","volume":"179","author":"Obeng","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2026.153389_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114547","article-title":"Antimicrobial cetylpyridinium chloride causes functional inhibition of mitochondria as potently as canonical mitotoxicants, nanostructural disruption of mitochondria, and mitochondrial Ca(2+) efflux in living rodent and primary human cells","volume":"186","author":"Weller","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2026.153389_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009877","article-title":"AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization","volume":"12","author":"Liu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2026.153389_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114423","article-title":"HIF-1\u03b1 inhibitor YC-1 suppresses triple-negative breast cancer growth and angiogenesis by targeting PlGF\/VEGFR1-induced macrophage polarization","volume":"161","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26001531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26001531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:07Z","timestamp":1777399507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26001531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":79,"alternative-id":["S0006291X26001531"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153389","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cetylpyridinium chloride inhibits the polarization of tumor-associated macrophages and the proliferation of triple-negative breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153389"}}